U.S. Capital Wealth Advisors, LLC Astrazeneca PLC Transaction History
U.S. Capital Wealth Advisors, LLC
- $3.48 Billion
- Q4 2025
A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 16,899 shares of AZN stock, worth $1.51 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
16,899
Previous 16,531
2.23%
Holding current value
$1.51 Million
Previous $1.27 Million
19.09%
% of portfolio
0.04%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,548Shares Held
503MCall Options Held
5.54MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...